How much is 1nhaler worth in 2026?

1nhaler has a current valuation of $13.8M based on their Later Stage VC round and secondary market data.

How much funding has 1nhaler raised?

1nhaler has raised $4.5M in total funding across 0 funding rounds.

1nhaler

Website

1nhaler valuation and funding history | Last updated: November 17, 2025

Current Valuation

$13.8M

As of November 17, 2025

Total Funding Raised

$4.5M

Last Round

Later Stage VC

$1.9M

Last Funding

Nov 2025

Funding date

Capital Efficiency

3.05x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

1nhaler is currently valued at $13.8M as of November 17, 2025. The company has raised a total of $4.5M in funding.

Capital Efficiency

With a capital efficiency ratio of 3.05x, 1nhaler has achieved a valuation that is 3.05 times the total capital raised.

Track 1nhaler Valuation Updates

Get notified when 1nhaler raises new funding or valuation changes

Explore More Data

Detailed analysis for 1nhaler

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock 1nhaler's valuation history, funding rounds, and growth metrics.

No credit card required

What is 1nhaler Worth in 2026?

1nhaler is a leading private company in the technology sector. Track 1nhaler's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How 1nhaler Valuation is Determined

Private company valuations like 1nhaler's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.